Literature DB >> 10598941

Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.

I Loubinoux1, K Boulanouar, J P Ranjeva, C Carel, I Berry, O Rascol, P Celsis, F Chollet.   

Abstract

Fluoxetine inhibits the reuptake of serotonin, and dextroamphetamine enhances presynaptic release of monoamines. Although the excitatory effect of both noradrenaline and dopamine on motor behavior generally is accepted, the role of serotonin on motor output is under debate. In the current investigation, the authors evidenced a putative role of monoamines and, more specifically, of serotonin in the regulation of cerebral motor activity in healthy subjects. The effects on cerebral motor activity of a single dose of fluoxetine (20 mg), an inhibitor of serotonin reuptake, and fenozolone (20 mg/50 kg), an amphetamine-like drug, were assessed by functional magnetic resonance imaging. Subjects performed sensorimotor tasks with the right hand. Functional magnetic resonance imaging studies were performed in two sessions on two different days. The first session, with two scan experiments separated by 5 hours without any drug administration, served as time-effect control. A second, similar session but with drug administration after the first scan assessed drug effects. A large increase in evoked signal intensity occurred in the ipsilateral cerebellum, and a parallel, large reduction occurred in primary and secondary motor cortices (P < 10(-3)). These results are consistent with the known effects of habituation. Both drugs elicited comparable effects, that is, a more focused activation in the contralateral sensorimotor area, a greater involvement of posterior supplementary motor area, and a widespread decrease of bilateral cerebellar activation (P < 10(-3)). The authors demonstrated for the first time that cerebral motor activity can be modulated by a single dose of fluoxetine or fenozolone in healthy subjects. Drug effects demonstrated a direct or indirect involvement of monoamines and serotonin in the facilitation of cerebral motor activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598941     DOI: 10.1097/00004647-199912000-00010

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  Emerging treatments for motor rehabilitation after stroke.

Authors:  Edward S Claflin; Chandramouli Krishnan; Sandeep P Khot
Journal:  Neurohospitalist       Date:  2015-04

2.  Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.

Authors:  Martin Dennis; John Forbes; Catriona Graham; Maree Hackett; Graeme J Hankey; Allan House; Stephanie Lewis; Erik Lundström; Peter Sandercock; Gillian Mead
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

Review 3.  Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients?

Authors:  Ruth A Lanius; Chris R Brewin; J Douglas Bremner; Judith K Daniels; Matthew J Friedman; Israel Liberzon; Alexander McFarlane; Paula P Schnurr; Lisa Shin; Murray Stein; Eric Vermetten
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

Review 4.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Lynn A Legg; Ann-Sofie Rudberg; Xing Hua; Simiao Wu; Maree L Hackett; Russel Tilney; Linnea Lindgren; Mansur A Kutlubaev; Cheng-Fang Hsieh; Amanda J Barugh; Graeme J Hankey; Erik Lundström; Martin Dennis; Gillian E Mead
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

Review 5.  Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery.

Authors:  Jean-Claude Baron; Leonardo G Cohen; Steven C Cramer; Bruce H Dobkin; Heidi Johansen-Berg; Isabelle Loubinoux; Randolph S Marshall; N S Ward
Journal:  Cerebrovasc Dis       Date:  2004       Impact factor: 2.762

6.  Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex.

Authors:  Giorgi Batsikadze; Walter Paulus; Min-Fang Kuo; Michael A Nitsche
Journal:  Neuropsychopharmacology       Date:  2013-05-17       Impact factor: 7.853

Review 7.  Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after Stroke.

Authors:  Janne Kaergaard Mortensen; Grethe Andersen
Journal:  CNS Drugs       Date:  2018-10       Impact factor: 5.749

Review 8.  Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Authors:  Gillian E Mead; Cheng-Fang Hsieh; Rebecca Lee; Mansur A Kutlubaev; Anne Claxton; Graeme J Hankey; Maree L Hackett
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

9.  Modulation of premotor cortex response to sequence motor learning during escitalopram intake.

Authors:  Eóin N Molloy; Karsten Mueller; Nathalie Beinhölzl; Maria Blöchl; Fabian A Piecha; André Pampel; Christopher J Steele; Ulrike Scharrer; Gergana Zheleva; Ralf Regenthal; Bernhard Sehm; Vadim V Nikulin; Harald E Möller; Arno Villringer; Julia Sacher
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-04       Impact factor: 6.200

Review 10.  Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model.

Authors:  François Chollet
Journal:  Dialogues Clin Neurosci       Date:  2013-03       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.